The Affirm prone breast biopsy system delivers faster, more comfortable procedures by increasing automation, providing superior imaging and giving 360° access to the breast, creating a better experience for patients and providers.1 For detailed product information, please visit www.affirmprone.com.
With high quality 2D or tomosynthesis (3D™) imaging and a field of view that’s more than 6.5 times larger than older generations of prone biopsy systems,¹ clinicians can visualize more tissue and pinpoint subtle lesions and faint calcifications that may not be visible on older systems. It also allows for easy software upgrade from 2D to 3D™ imaging at any time.
Featuring an automated tube-head motion, pre-programmed needle parameters and one-click targeting, the Affirm prone biopsy system is streamlined for efficiency. Its intuitive software and increased automation foster a faster, more efficient workflow, and fewer procedural steps help reduce the chance of manual errors.1
A fully integrated C-arm and bidirectional patient positioning provide a new level of 360° access to the breast, improving access to some of the most challenging lesions.¹ The system features an independently rotating biopsy arm and exclusive lateral needle approach that allows clinicians to switch from a standard to lateral approach in seconds—without additional attachments and without the need to reposition the patient or acquire additional images.
More than 95% of patients reported their Affirm® prone biopsy procedure was faster, more comfortable and less painful than expected.3 The system is designed with patients’ physical and emotional comfort in mind. Direct view of the biopsy needle is eliminated, helping reduce patient stress, and clinicians can quickly identify, target and access lesions to help reduce time spent in compression.¹
The Affirm biopsy system is available in two configurations to meet your facility’s needs.
- The 2D biopsy configuration provides traditional 2D stereotactic biopsy capabilities while also providing superior imaging, a faster easier workflow and improved access to the breast.¹
- The 3D™ biopsy configuration provides all of the capabilities of the 2D configuration, but also adds tomosynthesis-guided biopsy.
Both systems include:
- Bi-directional elevating patient support platform.
- Fully integrated and independently rotating tube-arm, biopsy arm, detector mechanism.
- Exclusive, fully integrated lateral needle approach.
- 180° continuous C-arm rotation.
- Under table and biopsy field work lights (LED, dimmable).
- High resolution color touchscreen biopsy control module.
- DICOM: Worklist, Query/Retrieve, Storage, Storage Commitment, Print.
- 1 set of Paddles: 5 cm x 5 cm (biopsy window) standard, 6 cm x 7 cm Standard, 5 cm x 5 cm axillary, 15 cm (total width) lateral.
- Fine needle guide accessory.
- 1 stool with backrest.
Adjustable height workstation:
- Electronic lift mechanism (40.7 cm vertical travel).
- Workflow display monitor: 17” 1280 x 1024 resolution.
- 2 MP or 3 MP DICOM image display monitors.
For complete details on the Affirm prone biopsy system technical specifications, please refer to the data sheet PDF.
References: 1. Compared to MultiCare® Platinum System 2. Compared to MultiCare® Platinum system and Mammotome MammoTest systems. 3. Survey of 209 patients post-procedure at 3 hospitals, 10 clinicians.
Women's Health Community Supported by Hologic
Comprehensive information on women’s health issues and management, management and personalisation.
Enterprise Imaging Community
Advanced and scalable radiology solutions that can help improve care coordination, increase speed and facilitate accurate clinical decisions.
Decision Support Community Supported by Siemens Healthineers
Leading the way in highlighting useful and efficient decision support tools for improved patient outcomes.
Sepsis Community Supported by Abionic
Addressing the latest developments in sepsis and providing clinically useful information for diagnosis and treatment of patients.
Contrast Agent Shortage Sends Ripples through Radiology
Radiology departments react to a shortage of iodinated contrast media... Read more
JOIN OUR MANAGEMENT COMMUNITY
Study Reveals Comedy, AI, and Self-Care Can Quickly Boost Patient Mental Health
Dramatic Reduction in Depression, Stress, and Anxiety Reported... Read more
SKIA Develops SKIA_Breast, AR Navigation on Patient Body for Doctors
SKIA Co., Ltd. (CEO Lee Jong-Myung) has introduced an innovative technology Read more
GE Healthcare and Medtronic Announce a Collaboration to Meet Growing Need for Outpatient Case
Providing excellent care inside and outside of the traditional hospital... Read more
Breaking Down the Barriers to Clinical Connectivity in Cardiology
The COVID-19 pandemic didn't create the universe of clinical connectivity... Read more
New JAMA Article Highlights the Outcome and Safety Benefits of Remote Patient Monitoring
Masimo SafetyNet® Reduced Mortality Among COVID-19 Patients... Read more
Sectra wins four 2022 Best in KLAS awards in the US, Canada, and Asia/Oceania
International medical imaging IT and cybersecurity company Sectra Read more
Ortho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available
Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated... Read more
New Fluoroscopy System From Siemens Healthineers Combines Industry-Leading Fluoroscopy & Radiography
Journées Francophones de Radiologie Diagnostique & Interventionnelle... Read more
DocPanel Welcomes Jaideep Sohi, MD as Chief Medical Officer
DocPanel, a global innovator in providing subspecialized radiology coverage... Read more
Eric Bohannon Joins Buoy Health Board of Directors
AI-powered health platform Buoy Health announced the addition of& Read more
Dr. Thomas E. MacGillivray Named Chair of Cardiac Surgery for MedStar Heart & Vascular Institute
MedStar Heart & Vascular Institute is pleased to announce that Thomas... Read more
Stanley H. Appel Receive MDA Tribute Award Honoring 40 Years of Critical Contributions in Medicine
The Muscular Dystrophy Association (MDA) today announced that Dr. Stanley... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY